In this study, we determined that metformin reduced the survival of lung cancer cells (Fig. 1), induced oxidative stress through increasing intracellular ROS and MDA levels while reducing intracellular GSH, T-SOD and CAT contents (Fig. 2), and increased the accumulation of cellular ferrous ions. This evidence concerns the gene CAT and lung carcinoma.